Early morphological changes in cardiac mitochondria after subcutaneous administration of trastuzumab in rabbits: possible prevention with oral selenium supplementation

Cardiovasc Pathol. 2020 Jan-Feb:44:107159. doi: 10.1016/j.carpath.2019.107159. Epub 2019 Oct 16.

Abstract

Trastuzumab-mediated cardiotoxicity poses a significant challenge in the treatment of human epidermal growth factor receptor 2-positive breast cancer. To understand the underlying mechanisms, we conducted experiments to determine ultrastructural changes of rabbit cardiac tissue under different experimental conditions, including differing doses of trastuzumab and supplementation with oral sodium selenite, an antioxidant. Histopathology revealed lymphocyte and macrophage infiltration in myocardium of rabbits receiving four doses of trastuzumab. Transmission electron microscopy showed substantial changes with trastuzumab, including edema with separation of myofibril bundles and rupture of sarcomeres. Within mitochondria, edema resulted in disorganization of the cristae. Some mitochondria exhibited eccentric projections of their membranes with disruption of both inner and outer membranes. These changes were seen to a lesser extent in rabbits who received oral sodium selenite prior to trastuzumab. Selenium is integral to functioning of mitochondrial glutathione peroxidases, important antioxidants that also maintain membrane integrity. If mitochondria are disrupted as part of trastuzumab cardiac toxicity, selenium supplementation might be an important therapeutic or preventive consideration. Larger studies to explore this hypothesis are warranted.

Keywords: Cardiotoxicity; Chemoprevention; Electron microscopy; HER2; Selenium; Trastuzumab.

MeSH terms

  • Administration, Oral
  • Animals
  • Antineoplastic Agents, Immunological / administration & dosage
  • Antineoplastic Agents, Immunological / toxicity*
  • Cardiotoxicity
  • Dietary Supplements*
  • Heart Diseases / chemically induced*
  • Heart Diseases / metabolism
  • Heart Diseases / pathology
  • Heart Diseases / prevention & control
  • Injections, Subcutaneous
  • Male
  • Mitochondria, Heart / drug effects*
  • Mitochondria, Heart / metabolism
  • Mitochondria, Heart / ultrastructure
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / ultrastructure
  • Pilot Projects
  • Rabbits
  • Sodium Selenite / administration & dosage*
  • Time Factors
  • Trastuzumab / administration & dosage
  • Trastuzumab / toxicity*

Substances

  • Antineoplastic Agents, Immunological
  • Sodium Selenite
  • Trastuzumab